
|Articles|June 29, 2022
Evaluating new atopic dermatitis medications for children
Author(s)Lois Levine, MA
At the 2022 Maui Derm NP+PA meeting in Colorado Springs, Colorado, a discussion of the newest biologics and how to "mix and match" medications and algorithms.
Advertisement
Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego, professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine, discussed the evaluation and use of new medications for atopic dermatitis for children, and how you need to "mix and match" biologics and alogrithms for optimal results.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
AAP issues guidance on providing medical care to parents during pediatric visits
2
AbbVie submits FDA, EMA applications for upadacitinib (RINVOQ) in non-segmental vitiligo for 12 years and older
3
Jeffrey Segar, MD, highlights sodium supplementation to support infant weight gain
4
Arcutis reports positive phase 2 data for roflumilast cream (Zoryve) in infants with atopic dermatitis
5






